NOVOZYMES A/S: cashflow_financing

Value{"amount": -977000000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"}
Period2023-07-01 – 2023-09-30
Statuscurrent
EntityNOVOZYMES A/S
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:529900T6WNZXD2R3JW38:2023-09-30
Retrieved: 2026-08-24T00:25:17.069978+02:00
Raw response sha256: 416ccebd3ec8e78d843492b27721817f…
Cite as: FACTANKER, https://factanker.com/fact/dd2f5aec-c5ef-4541-8af5-e1fc8a002abc

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies